-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on PTC Therapeutics, Lowers Price Target to $82

Benzinga·02/20/2026 14:43:38
Listen to the news
RBC Capital analyst Brian Abrahams maintains PTC Therapeutics (NASDAQ:PTCT) with a Sector Perform and lowers the price target from $87 to $82.